Current Status and Global Application of Immune Checkpoint Inhibitor Therapy in Endometrial Cancer

Gain insights from international experts on current best practice and emerging strategies for immune checkpoint inhibition in patients with endometrial cancer.

This educational program is intended for clinicians practicing medicine outside of the United States.

Share

Program Content

Activities

子宫内膜癌 IO
子宫内膜癌分子学重新分类:确定适合接受免疫治疗的患者
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 26, 2021

Expires: March 25, 2022

子宮内膜がん IO
子宮体癌の分子再分類:免疫療法の対象となる患者の特定
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 30, 2021

Expires: March 29, 2022

Cancro endometriale IO
Riclassificazione molecolare del cancro dellendometrio: identificazione dei pazienti idonei per limmunoterapia
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 29, 2021

Expires: April 28, 2022

進行/再発 EC における ICI
免疫チェックポイント阻害剤を用いた進行・再発子宮体癌治療について
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 28, 2021

Expires: July 27, 2022

ICI en CE avanzado/recurrente
Gestione del tumore endometriale avanzato o ricorrente con inibitori del checkpoint immunitario
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 28, 2021

Expires: July 27, 2022

ICI 治疗晚期/复发性子宫内膜癌 (EC)
使用免疫检测点抑制剂治疗晚期或复发性子宫内膜癌
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2021

Expires: July 28, 2022

ICI en CE avanzado/recurrente
Manejo de cáncer de endometrio avanzado o recurrente con inhibidores de puntos de control inmunológico.
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2021

Expires: July 28, 2022

Inmunoterapia contra el cáncer de endometrio
Reclasificación molecular del cáncer de endometrio: Identificación de pacientes elegibles para la inmunoterapia
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022
ICI pour les cancers de lendomAtre
Prise en charge des cancers de la۪endomA tre avanc̩s ou en rechute par les inhibiteurs des points de contrAle immunitaire.
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022
Immuno-oncologie du cancer de lendomA tre
Reclassification moléculaire du cancer de lendomAtre: identification des patientes susceptibles de bA©nA©ficier de limmunothA©rapie.
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Activities

Endometrial Cancer IO
Molecular Reclassification of Endometrial Cancer: Identifying Patients Eligible for Immunotherapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2021

Expires: February 24, 2022

ICI in Advanced/Recurrent EC
Managing Advanced or Recurrent Endometrial Cancer With Immune Checkpoint Inhibitors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 28, 2021

Expires: June 27, 2022

Faculty

cover img faculity

Maria-Pilar Barretina-Ginesta, MD

Associate Professor
Medical Sciences Department
Girona University
Assistant Chief
Medical Oncology Department
Institut Catala D Oncologia
Girona, Spain

cover img faculity

Domenica Lorusso, MD, PhD

Associate Professor 
Catholic University of Sacred Heart
Haear of Clinical Research Development Unit
Fondazione Policlinico Gemelli IRCCS
Rome, Italy

Supporters

Supported by an educational grant from

GlaxoSmithKline